Lnk Intl Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LNK INTL INC, and what generic and branded alternatives to LNK INTL INC drugs are available?
LNK INTL INC has one approved drug.
Summary for Lnk Intl Inc
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Lnk Intl Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lnk Intl Inc | NAPROXEN SODIUM | naproxen sodium | TABLET;ORAL | 204872-001 | Jan 23, 2017 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
